| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.077 | 0.1 |